Email This Release
Genzyme and Isis Announce Filing of U.S. NDA for KYNAMRO™ (mipomersen sodium) in Homozygous Familial Hypercholesterolemia
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words:
Terms of Use
|
© 2024 Business Wire